found that let-7a acts as a tumor suppressor in prostate cancer by down-regulating E2F2 and CCND2, further study shown that the 3’UTR of E2F2 and CCND2 could directly bind to let-7a and then induce cell cycle arrest at the G1/S phase (40). Here, CCND2 is linked to prostate cancer.